SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery

Since the publication of the Society for Immunotherapy of Cancer’s (SITC) original cancer immunotherapy biomarkers resource document, there have been remarkable breakthroughs in cancer immunotherapy, in particular the development and approval of immune checkpoint inhibitors, engineered cellular ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu-Lieskovan, Siwen, Bhaumik, Srabani, Dhodapkar, Kavita, Grivel, Jean-Charles J B, Gupta, Sumati, Hanks, Brent A, Janetzki, Sylvia, Kleen, Thomas O, Koguchi, Yoshinobu, Lund, Amanda W, Maccalli, Cristina, Mahnke, Yolanda D, Novosiadly, Ruslan D, Selvan, Senthamil R, Sims, Tasha, Zhao, Yingdong, Maecker, Holden T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Position Article and Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713206/
https://www.ncbi.nlm.nih.gov/pubmed/33268350
http://dx.doi.org/10.1136/jitc-2020-000705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713206/
https://www.ncbi.nlm.nih.gov/pubmed/33268350
http://dx.doi.org/10.1136/jitc-2020-000705

Ejemplares similares